Results 231 to 240 of about 669,579 (283)
How to enhance primary healthcare capacity? Evidence from Chinese provinces through a configurational lens. [PDF]
Wang F, Wang Y, Yang J, Li L.
europepmc +1 more source
This study identifies the transcription factor ETV1 as a key driver of CD4⁺ T cell‐mediated intestinal inflammation in inflammatory bowel disease (IBD). ETV1 promotes CD4⁺ T cell activation, proliferation, and Th17 differentiation by activating the amino acid transporter SLC7A5, fueling metabolic reprogramming.
Yan Shi +8 more
wiley +1 more source
Key factors associated with China's basic medical insurance fund revenue-expenditure balance: a grey relational analysis. [PDF]
Gong G, Dan W, Wei H, Xiping L.
europepmc +1 more source
Cryopreserved lung‐humanized mice overcome the dependency to fresh tissues and permit head‐to‐head profiling of all four human common cold coronaviruses versus SARS‐CoV‐2 infection; the model validates Paxlovid efficacy against HKU1 and, when coupled with human immune‐system engraftment, enables interrogation of lung‐resident human immunity and HKU1 ...
Chunyu Cheng +9 more
wiley +1 more source
Data Sharing business and revenue models
This document will compile a set of business and revenue models for the stakeholders interested in enhancing their data sharing products and services especially Data Providers Service Providers Governments through the MobiDataLab Transport Cloud Related task ...
openaire +1 more source
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation
METTL5 reshapes the tumor immune microenvironment through ribosome 18S rRNA m6A modification to regulate the translation of chemokine mRNA. Targeting METTL5‐mediated immunosuppression unleashes anti‐tumor immunity and improves the efficacy of anti‐PD‐1 therapy.
Shuang Li +19 more
wiley +1 more source
Framework for effective collaboration in telemedicine-based healthcare consortium in the 5G era: a case study in China. [PDF]
Wan M, Wang Y, Qiao Y, Shukla N.
europepmc +1 more source
PBRM1 ranks as the second most commonly mutated gene in ccRCC. This study reveals that PBRM1 loss promotes an immunosuppressive microenvironment by elevating M2 TAMs via the KDM5C–IL‐6 axis. These M2 TAMs, along with CAFs, form a barrier that excludes CD8+ T cells. Targeting IL‐6 synergizes with anti‐PD1 therapy, offering a promising strategy for PBRM1‐
Wenjiao Xia +14 more
wiley +1 more source
F-TransR: A sports event revenue prediction model integrating multi-modal and time-series data. [PDF]
You G, Guo K, Gao J, Feng H, Zou W.
europepmc +1 more source

